Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Natalie Douglas, CEO of Idis, Joins Global Genes | RARE Project Board of Directors

ALISO VIEJO, California and PRINCETON, New Jersey, Feb. 12, 2013 /PRNewswire/ -- Global Genes | RARE Project and Idis are pleased to announce the addition of Natalie Douglas, CEO of Idis, to the Global Genes | RARE Project Board of Directors.  

Throughout her career and now as CEO of Idis, Douglas has pursued the cause for providing access to medicines for patients with unmet medical needs.   Her experience in the pharmaceutical industry introduced her to the therapeutic challenges for physicians in managing the unmet medical needs of patients including those with cancer and AIDS.

As an organization, Idis reflects the deep commitment and compassion embodied by Douglas for patients in the rare disease community.   In 2012 alone, Idis helped more than 720,000 patients, including many with rare diseases, gain access to critical therapies.  The results-driven mindset of the organization has helped patients gain access even in the most challenging situations.

Recognizing the complex nature of addressing unmet medical needs, Douglas is a passionate advocate for creating more meaningful, productive connections between industry, regulatory authorities, and the patient advocacy community to identify and remove barriers to access. 

"We are honored to have Natalie join our Board of Directors; her passion and commitment to rare disease and its community is more than evident in all she does both personally and professionally.  She will bring tremendous value and insights to the organization as it works to create a larger impact globally," stated Nicole Boice, Founder/President Global Genes | RARE Project.

"Addressing the unmet medical needs in the rare disease community is especially challenging," noted Douglas.  "The Global Genes | RARE Project has created a much needed voice for these patients and their families.  I am delighted to join the board of an organization that has made such an impact for an underserved population and look forward to contributing to their important mission." 

The addition of Ms. Douglas to the Board of Directors will be the first of many announcements this year from Global Genes | RARE Project, as the organization works to secure additional board members that bring important expertise to this growing organization.

"Our organization is entering an important period of growth, expectations have increased, and Global Genes | RARE Project wants to ensure that it continues to deliver increased value to those whom we serve - the rare disease patient advocacy community," stated Boice.   

About Global Genes | RARE Project
Global Genes | RARE Project is a leading global rare and genetic disease patient advocacy organization.  Global Genes | RARE Project works to build and unify a global rare and genetic disease community and positively impact patients in their lifetime by offering programs designed to educate, empower, and support patients, advocates, foundations, and other rare disease focused organizations. www.globalgenes.org 

About Idis
Idis has 25 years experience of partnering with pharmaceutical and biotechnology companies to create regulatory-compliant, ethical access to medicines for healthcare professionals and their patients with unmet medical needs. Since 1987, Idis has developed and managed access to thousands of medicines from every therapeutic category, impacting the lives of hundreds of thousands of patients in countries around the world.  Idis leverages decades of experience, regulatory insight, and a thorough understanding of local and global requirements to create access to medicines at every stage of a product's lifecycle from pre-approval to market exit, and in times of unexpected production shortages.  The company's international headquarters are located in Weybridge, United Kingdom, and North American headquarters are located in Princeton, NJ. For more information, visit www.idispharma.com.

Contacts:  
Global Genes | RARE Project
Carrie Ostrea
Phone: +1-949-248-7273
Email: carrieo@rareproject.org

Idis
Christine Quern
Feinstein Kean Healthcare
Phone: +1-617-761-6791
Email: Christine.quern@fkhealth.com

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
DoubleDown Interactive, a provider of online free-to-play casino games, needs to process huge amounts of streaming event data from their games and make that data rapidly available to data scientists and analysts. Hear how Amazon S3 and Snowflake’s Elastic Data Warehouse have made it po...
Major product cycle changes tend to come around roughly every five years or so. The technology industry is fond of labeling these movements as paradigm shifts, but we’ve all heard too many of those things referenced, so let’s not go there. Looking back over the last decade and the eme...
I recently saw an unusual post online that caught my eye. It was a standard weather radar picture from a Wisconsin TV Station (WFRV-TV Ch. 5). In the image you can see a large green area that normally denotes rain. What particularly caught my eye was that this image labeled the large g...
One reason a lot of entrepreneurs flock to cloud-based services for their business is the cost. Native applications require licenses that are either too expensive or require elaborate set-up across all devices. In a recent article on the Entrepreneur, Bask Iyer, the CIO and Senior Vic...
It’s enough to drive a regular IT market watcher to the point of despair. There has been a wide-ranging change in the way business operates driven by technology-driven transformation – could there ever be a more obvious statement to make, ever? The problem is how does it all work? T...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE